Zydus Cadila receives USFDA tentative approval for Brivaracetam Tablets

Read more about Zydus Cadila receives USFDA tentative approval for Brivaracetam Tablets on Business Standard. The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad. The group now has 319 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04.

Related Keywords

Ahmedabad ,Gujarat ,India ,Zydus Cadila , ,Brivaracetam Tablets ,Briviact Tablets ,Capital Market ,Branches Of Biology ,Anticonvulsants ,Chemistry ,Iology ,Racetams ,Brivaracetam ,Magnesium In Biology ,Mg Cars ,Cadila Healthcare ,Generic Pharmaceuticals ,Epilepsy ,Formulation Manufacturing Facility ,Seizures ,அஹமதாபாத் ,குஜராத் ,இந்தியா ,ஜய்துச் காடிலா ,மூலதனம் சந்தை ,கிளைகள் ஆஃப் உயிரியல் ,